Chelsea Therapeutics International Ltd. (CHTP)
$2.25
-0.05 (-2.17%)
| CAPS Rating |
|
|---|---|
| Open | $2.27 |
| Previous Close | $2.30 |
| Daily Range | $2.25 - $2.28 |
| 52-Week Range | $1.09 - $7.51 |
| Market Cap | $75.38M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 107,444 |
| Average Daily Volume | 488,000 |
CHTP
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CHTP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CHTP News and Commentary
- UPDATE 1-Chelsea says data on hypotension drug positive, shrs up – Reuters
- UPDATE 1-Chelsea's hypotension drug fails trial, shares plunge – Reuters
- RPT-PREVIEW-Chelsea's hypotension drug likely to meet trial goal – Reuters
- PREVIEW-Chelsea's hypotension drug likely to meet trial goal – Reuters
- Today's 5-Star Movers – The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
RSS Headlines
Fool UK
